DA Davidson Comments on Cognex’s Q2 Earnings (NASDAQ:CGNX)

Cognex Co. (NASDAQ:CGNX) – Investment analysts at DA Davidson issued their Q2 2025 earnings per share (EPS) estimates for shares of Cognex in a report released on Monday, May 5th. DA Davidson analyst M. Summerville anticipates that the scientific and technical instruments company will post earnings per share of $0.17 for the quarter. DA Davidson has a “Neutral” rating and a $32.00 price objective on the stock. The consensus estimate for Cognex’s current full-year earnings is $0.61 per share. DA Davidson also issued estimates for Cognex’s FY2026 earnings at $0.81 EPS.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, February 12th. The scientific and technical instruments company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). Cognex had a net margin of 11.61% and a return on equity of 5.65%.

CGNX has been the subject of a number of other research reports. Robert W. Baird cut their price objective on shares of Cognex from $42.00 to $38.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. UBS Group cut their price target on Cognex from $56.00 to $53.00 and set a “buy” rating for the company in a research note on Friday, May 2nd. HSBC downgraded Cognex from a “buy” rating to a “hold” rating and set a $33.00 price target on the stock. in a research report on Friday, February 21st. Truist Financial cut their price objective on Cognex from $37.00 to $29.00 and set a “hold” rating for the company in a research report on Tuesday, April 8th. Finally, Needham & Company LLC decreased their target price on Cognex from $41.00 to $33.00 and set a “buy” rating on the stock in a research report on Thursday, May 1st. One analyst has rated the stock with a sell rating, seven have given a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $39.17.

Cognex Price Performance

NASDAQ:CGNX opened at $27.83 on Tuesday. The company has a 50 day moving average price of $28.31 and a 200-day moving average price of $34.77. Cognex has a 1-year low of $22.67 and a 1-year high of $53.13. The firm has a market cap of $4.71 billion, a price-to-earnings ratio of 45.62 and a beta of 1.45.

Cognex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, May 15th will be given a dividend of $0.08 per share. The ex-dividend date is Thursday, May 15th. This represents a $0.32 dividend on an annualized basis and a yield of 1.15%. Cognex’s payout ratio is presently 47.06%.

Insider Activity at Cognex

In other Cognex news, EVP Carl Gerst sold 6,803 shares of the company’s stock in a transaction on Monday, February 24th. The stock was sold at an average price of $32.73, for a total value of $222,662.19. Following the completion of the sale, the executive vice president now directly owns 4,566 shares in the company, valued at $149,445.18. This represents a 59.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Cognex

Hedge funds have recently modified their holdings of the company. Charles Schwab Investment Management Inc. boosted its holdings in Cognex by 3.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,427,756 shares of the scientific and technical instruments company’s stock valued at $51,199,000 after purchasing an additional 42,292 shares during the last quarter. Smartleaf Asset Management LLC lifted its holdings in Cognex by 75.1% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the scientific and technical instruments company’s stock valued at $102,000 after acquiring an additional 1,231 shares during the last quarter. Swiss National Bank grew its position in Cognex by 0.7% in the fourth quarter. Swiss National Bank now owns 337,300 shares of the scientific and technical instruments company’s stock worth $12,096,000 after acquiring an additional 2,200 shares during the period. Merit Financial Group LLC acquired a new stake in Cognex during the fourth quarter worth $267,000. Finally, Covea Finance raised its position in Cognex by 54.7% in the fourth quarter. Covea Finance now owns 73,500 shares of the scientific and technical instruments company’s stock valued at $2,636,000 after purchasing an additional 26,000 shares during the period. Hedge funds and other institutional investors own 88.12% of the company’s stock.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.